Literature DB >> 34695794

Case Report: Anaphylactoid Shock Associated with Snakebite Envenoming in Portugal.

António Lamas1, Joana Fragoso2, Marli Ferreira1, Ana Cipriano2, Rute Alves3.   

Abstract

Although rare in Portugal, snakebite envenoming entails severe morbidity and mortality. We present the case of a 65-year-old woman bitten on her leg in a northern coastal region in Portugal, on a walk during the COVID-19 pandemic lockdown. Despite first looking for help at the nearest pharmacy, she developed anaphylactoid shock and was promptly driven to a tertiary hospital, where antivenom was administered in a timely manner under close monitoring. Prophylactic antibiotics were started and maintained based on elevated inflammatory markers and signs of wound inflammation. She evolved favorably, with rapid weaning of vasopressors and resolution of end-organ dysfunction. This case highlights the importance of prompt recognition and describes crucial steps in envenomation management in a country where snakebite is infrequent, but potentially fatal.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34695794      PMCID: PMC8733493          DOI: 10.4269/ajtmh.21-0671

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  16 in total

1.  Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper).

Authors:  Y Komori; T Nikai; K Taniguchi; K Masuda; H Sugihara
Journal:  Biochemistry       Date:  1999-09-07       Impact factor: 3.162

2.  Are anaphylactic reactions to snake bites immunoglobulin E-mediated?

Authors:  A R Reimers; M Weber; U R Müller
Journal:  Clin Exp Allergy       Date:  2000-02       Impact factor: 5.018

3.  Snake bites by European vipers in Mainland France in 2017-2018: comparison of two antivenoms Viperfav® and Viperatab®.

Authors:  David Boels; Jean François Hamel; Gaël Le Roux; Magali Labadie; Nathalie Paret; Nicolas Delcourt; Jérôme Langrand; Emmanuel Puskarczyk; Patrick Nisse; Sandra Sinno-Tellier; Luc de Haro
Journal:  Clin Toxicol (Phila)       Date:  2020-03-05       Impact factor: 4.467

4.  European viper envenomings: Assessment of Viperfav™ and other symptomatic treatments.

Authors:  David Boels; Jean Francois Hamel; Marie Bretaudeau Deguigne; Patrick Harry
Journal:  Clin Toxicol (Phila)       Date:  2012-03       Impact factor: 4.467

Review 5.  Antivenom for European Vipera species envenoming.

Authors:  Thomas Lamb; Luc de Haro; Davide Lonati; Miran Brvar; Michael Eddleston
Journal:  Clin Toxicol (Phila)       Date:  2017-03-28       Impact factor: 4.467

Review 6.  Snakebite envenoming.

Authors:  José María Gutiérrez; Juan J Calvete; Abdulrazaq G Habib; Robert A Harrison; David J Williams; David A Warrell
Journal:  Nat Rev Dis Primers       Date:  2017-09-14       Impact factor: 52.329

Review 7.  Vipera snakebite in Europe: a systematic review of a neglected disease.

Authors:  G Paolino; M R Di Nicola; A Pontara; D Didona; E Moliterni; S R Mercuri; M Grano; N Borgianni; R Kumar; R Pampena
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-07-20       Impact factor: 6.166

8.  Clinical aspects of bites by viper in Spain.

Authors:  D González
Journal:  Toxicon       Date:  1982       Impact factor: 3.033

Review 9.  Renal effects and injury induced by animal toxins.

Authors:  Visith Sitprija; Siravit Sitprija
Journal:  Toxicon       Date:  2012-06-29       Impact factor: 3.033

10.  Asp Viper (Vipera aspis) envenomation: experience of the Marseille Poison Centre from 1996 to 2008.

Authors:  Luc de Haro; Mathieu Glaizal; Lucia Tichadou; Ingrid Blanc-Brisset; Maryvonne Hayek-Lanthois
Journal:  Toxins (Basel)       Date:  2009-11-24       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.